Comparative antineoplastic activity against P388 leukemia of 9-beta-D-arabinofuranosyladenine (araA) and 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl) adenine (arazide).
D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002478:Cells, Cultured; D003070:Coformycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004359:Drug Therapy, Combination; D007941:Leukemia P388 / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D015649:Pentostatin; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D058892:Adenosine Deaminase Inhibitors; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D003070:Coformycin; D015649:Pentostatin; C020605:arazide; D014740:Vidarabine